OUR VISION
To improve global healthcare by increasing the availability of biotechnology medicines.
OUR MISSION
To develop and manufacture high quality biologics at affordable prices through manufacturing innovation, state-of-the-art technologies to ensure all patient needs are addressed and met and to promote and accelerate the success of our clients.
OUR VALUES
At Eden Biologics, we value and foster an environment for continuous learning, encourage open communication and team building, building trust with our clients, and emphasize the importance of cGMP with tight CMC strategies to produce the highest quality biologics.
Eden Biologics, Inc. Announces the Completion of the Sale of CDMO Business Assets
Hsinchu, Taiwan, July 6th, 2022 To Eden Biologics Investors, Partners, Colleagues and Friends: I would like to take this opportunity... read more →
2022-07-06
Eden Biologics Introduces New Chief Executive Officer, Dr. Steve Lee
Hsinchu, Taiwan, September 1st, 2021 - Eden Biologics, Inc., a leading global biotechnology company based in Hsinchu, Taiwan, announced on... read more →
2021-09-01
Eden Biologics’ Leading Biosimilar Program Receives Phase 3 Approval in Europe
We’ve once again achieved a huge corporate milestone and are excited to share the great news with all of you! ... read more →
2021-08-31
Eden Biologics Statement
Hsinchu, Taiwan, July 9th, 2021 – Earlier this week, the United States Department of Justice announced that it has filed... read more →
2021-07-09
Eden Biologics Proudly Announces Dr. Scott Liu as Board Member
Hsinchu, Taiwan, March 15th, 2021 – Eden Biologics is honored to announce the addition of Dr. Scott Liu as a... read more →
2021-03-15
Eden Biologics Anticipates Initiation of Global Phase 3 in 2021 H2 for Its Denosumab Biosimilar
Hsinchu, Taiwan, 25th February, 2021 – Eden Biologics, Inc., a global frontrunner in biological drug development and manufacturing platform technologies,... read more →
2021-02-25
Our Partners & Investors
Are you ready to inquire now?